Presentation of the BioRegion of Catalonia

623 views

Published on

The BioRegion is the health and life sciences cluster in Catalonia, meaning the group of companies, research groups and bodies, hospitals, universities, administrations, researchers and entrepreneurs, innovation and knowledge-transfer support structures working in Catalonia in this strategic sector.

Published in: Healthcare
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
623
On SlideShare
0
From Embeds
0
Number of Embeds
4
Actions
Shares
0
Downloads
20
Comments
0
Likes
1
Embeds 0
No embeds

No notes for slide

Presentation of the BioRegion of Catalonia

  1. 1. BIOREGION OF CATALONIA www.biocat.cat
  2. 2. BARCELONA CATALONIA @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia WITHALONGINDUSTRIALTRADITION,CATALONIAHAS ADENSEANDINNOVATIVEINDUSTRIALCOMMUNITY •6%OFSPANISHTERRITORY •16%OFPOPULATION(7.5MINHABITANTS) •20%OFGDP •47%OFPHARMACEUTICALINDUSTRY •19.4%OFBIOTECHNOLOGICALINDUSTRY •23%OFINVESTMENTINR&D BARCELONALEADSTHETOP10MAJOR EUROPEANCITIESOFTHEFUTURE2016/2017 CATALONIAISTHEFOURTHREGIONINALLOF EUROPEINTERMSOFFOREIGNINVESTMENT ATTRACTIONIN2015 Sources: Farmaindustria, Asebio, Financial Times' FDI Markets
  3. 3. THEBIOREGIONOFCATALONIA,AGROWINGAND INNOVATIVEECOSYSTEM Source: Biocat Directory (September 2015) 734 89 COMPANIES RESEARCH ORGANIZATIONS @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia BIOTECH PHARMA MEDTECH (R&D) SUPPLIER & ENGINEERING PROFESSIONAL SERVICES INVESTMENT ENTITIES RESEARCH CENTERS UNIVERSITY HOSPITALS UNIVERSITIES SCIENCE & TECHNOLOGY PARKS TECHNOLOGY CENTERS LARGE FACILITIES 221 46 94 208 139 26 41 15 11 13 7 2 (OUT OF 101 HOSPITALS) (OFFERING LIFE SCIENCES STUDIES)
  4. 4. SINCE2000,CATALONIAHASDEVELOPEDITSOWN SUCCESSFULRESEARCHECOSYSTEM 2000 KEYSUCCESSFACTORS: •Sustainedfundingfrom CatalanGovernment •Researchcentersautonomy •Independentevaluation •Fundingbasedonresults •Highperformanceinattracting EUfunds •Opentalentrecruitment program(ICREA) 2016 @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia
  5. 5. EMPLOYMENTANDRESOURCES COMPANIES RESEARCHCENTERS HOSPITALS +5,000RESEARCHERS 8,700WORKERS +89,000WORKERS 5,499RESEARCHERS (EMPLOYEDBYTHEUNIVERSITYHOSPITALS ANDRESEARCHINSTITUTES) (195ESTABLISHMENTS) 42,133 BIOTECH 14,278 PHARMA 9,989 OTHERS 6,622 MEDTECH 11,244 WORKERS COMPANIESHADREVENUESOF 14,369M€ANDCONTRIBUTED WITH7%TOTHEGDP INCATALONIA IN10YEARS,WORKERSINR&DHAVE INCREASED50%ANDRESEARCHERS60% Sources: Biocat Directory (Dec. 2014), Catalan Union of Hospitals, Government of Catalonia and SAVI @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia
  6. 6. R&DSPENDINGINCATALONIAREPRESENTS 1.5%OFGDP(2,938M€) Source: Farmaindustria, INE (2014) 23%OFSPANISHINVESTMENTINR&D 355M€ PHARMA INDUSTRY 147M€ BIOTECH COMPANIES 666M€ UNIVERSITIES @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia
  7. 7. ANINTERNATIONALCOMPETITIVER&DSYSTEM Source: Government of Catalonia 1 2 3 2 UNIVERSITIES AMONG THE 200 BEST IN THE WORLD (UB, UAB) 3 UNIVERSITIES AMONG THE 50 BEST UNDER 50 YEARS (URV, UAB, UPF) 19TH BEST STUDENT CITY OF THE WORLD BARCELONA TOTAL AMOUNT OF UNIVERSITIES WORLDWIDE (APROX.): 30,000 1 UNIVERSITY AMONG THE 49 TOP UNIVERSITIES IN THE WORLD IN SCIENTIFIC PRODUCTION (UB) CRG 9TH IN THE TOP 100 BEST BIOMEDICAL CENTERS IN THE WORLD Scimago Report (SIR 2013) ICIQ 1ST WORLD INSTITUTION IN CHEMISTRY Max Plank Institute (2014) ICFO 1ST WORLD INSTITUTION IN PHYSICS Max Plank Institute (2013) URAP (2015-2016) QS TOP-50 UNIVERSITIES UNDER 50 YEARS (2014) QS BEST STUDENTS CITIES 2015 @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia TIMES HIGHER EDUCATION (2015)
  8. 8. 33.4 32.8 22.2 18.2 6.7 ARTICLES PER MILLION INHABITANTS(2008-2012) RESEARCHERSWORKINGINCATALONIAPUBLISHATLEVELS COMPARABLETOTHOSEOFTHELEADINGEUROPEAN COUNTRIES Source: Government of Catalonia WITHOUT CATALONIA Intermsofpublicationsin Science&Nature,Catalonia doublesinnumberscountries suchasGermanyorFrance @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia
  9. 9. Source: Scopus / Observatori de la Recerca (OR-IEC), Institut d’Estudis Catalans CATALONIAPRODUCES3.15%OFALLSCIENTIFIC PRODUCTIONINEUROPEAND0.99%INTHEWORLD, AND29%OFPUBLICATIONSINSPAIN THENUMBEROFLIFESCIENCES ANDHEALTHCAREPUBLICATIONS ROSE168%FROM2000TO2015 @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia Publications (life sciences) % EU28 % world 20092004 20112006 20102005 20082003200220012000 20122007 2013 2014 2015 4% 5% 2% 3% 1% 0% 10K 12,5K 5K 7,5K 2,5K 0K
  10. 10. With27grantspermillion inhabitants,Cataloniaranks4th intheEuropeanResearchArea and2nd intheEuropeanUnion THEMORECHALLENGINGANDCOMPETITIVEACALLIS, THEBETTER CATALONIAPERFORMS @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia COUNTRY ERC GRANTS PER MILLION INHABITANTS (2007-2015) 51.9 46.3 34.5 27.3 23 21.1 18.3 17.9 16.2 17.3 14.8 11.9 11.9 11.0 10.7 10 8.3 9.3 5.8 5.6 5.0 3.7 4.7 3.1 3.0 22.4 EUROPEANRESEARCHCOUNCIL(ERC)CALLSARETHEMOSTRESTRICTIVEAMONG EU'SCALLS(LESSTHAN10%APPLICATIONSAREAWARDED)
  11. 11. Source: AGAUR from Eurostat 2013 / CORDA 2015 CATALONIAHASATTRACTED73%MOREFUNDSFROMTHEH2020THANTHETWOFIRSTYEARSOFTHEFP7. ThetwofirstyearsofH2020,Cataloniareceived226.8M€.ComparedtoothercountriesfromtheEuropean ResearchArea(ERA)andwithsimilarpopulation,CataloniaovercomesIsraelandSwitzerland inabsolutefigures H2020FUNDSATTRACTEDTOCATALONIA SHOWTHECOMPETITIVINESSANDEXCELLENCEOF INSTITUTIONS,COMPANIESANDRESEARCHERS @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia DENMARK FINLAND AUSTRIA CATALONIA ISRAEL SWITZERLAND 14 20 31 37 41 30 Country Inhabitants (in M) M€ Funding received per population (ratio) DENMARK FINLAND AUSTRIA CATALONIA ISRAEL SWITZERLAND 5,603 5,427 8,489 7,547 7,797 8,037 230.33 119.79 265.73 226.77 154.91 108.67 41 37 31 30 20 14
  12. 12. AWIDERANGEOFCUTTING-EDGEFACILITIESTHAT SUPPORTTHER&DSYSTEM @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia CENTER FOR GENOMIC REGULATION (CRG) BARCELONA SUPERCOMPUTING CENTER (BSC - CNS) ALBA SYNCHROTRON-CELLS BARCELONA BIOMEDICAL RESEARCH PARK (PRBB) BARCELONA SCIENCE PARK (PCB) ANDBRINGTOGETHER THEPLAYERSOFTHE VALUECHAIN: UNIVERSITIES,RESEARCH CENTERSANDCOMPANIES MORETHAN100PLATFORMS 2LARGEINFRASTRUCTURESOFRESEARCH 13SCIENCEANDTECHNOLOGYPARKS
  13. 13. @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia 41RESEARCHCENTERS 5,499RESEARCHERS 8,716EMPLOYEES 780RESEARCHGROUPS WORKINGONLIFE SCIENCES NEWINITIATIVESANDGROUPINGS2015: Barcelona Institute of Science and TechnologyBIST + +
  14. 14. Source: Farmaindustria, IASIST (2015) @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia 15UNIVERSITYHOSPITALSAND 9HOSPITALRESEARCHINSTITUTES CATALONIA, THEFOREMOSTREGION INSPAININTERMSOF CLINICALRESEARCH (2004-2011) 11OUTOFTHE TOP20BESTHOSPITALS INSPAINARELOCATED INCATALONIA 1ST POSITIONPERFORMINGCLINICAL TRIALS(27.3%)
  15. 15. @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia AHOTSPOTFORBUSINESSANDINNOVATION Biotechnology- Therapeutics and diagnostics Supplier & Engineering Investment entities Professional Services and Consulting Biotechnology - Other Pharma Biotechnology - R&D services Medical Technology Source: Biocat Directory 734companies 6% 30% 13% 11% 28% 19% 13% 6% 4% Biotech Pharma Medtech Others TURNOVER (M€) COMPANIES 9,9892,910 14,2786,852 11,2443,092 6,6221,514 14,369M€ 42,133(4,000 in R&D) 7%GDPOFCATALONIA WORKERS
  16. 16. @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia Source: Site Selection for Life Sciences Companies in Europe 2015. KPMG & Venture Valuation WHENCOMPARINGNUMBEROFCOMPANIESINEUROPE, CATALONIAISWITHINTHETOP5LEADINGCOUNTRIES DESPITEBEINGAMONGTHE 5SMALLESTCOUNTRIES,CATALONIASTANDS INTHETOP5 INNUMBEROFCOMPANIESINALLSECTORS Permillioninhabitants: - Biotechcompanies: Cataloniastandsin4th positionafterSweden, SwitzerlandandIsrael - Medtechcompanies: Cataloniastandsin4th positionafterIsrael, SwedenandSwitzerland - Pharmacompanies: Cataloniastandsin2nd position,afterBelgium Million Inhabitants 2016 Biotech companies Biotech Therapeutics companies Medtech R&D companies Pharma companiesPer capita Per capita Per capita Per capita AUSTRIA 8.713 94 10.79 40 4.59 52 5.97 15 1.72 BELGIUM 11.338 265 23.37 50 4.41 135 11.91 74 6.53 DENMARK 5.721 137 23.95 58 10.14 71 12.41 10 1.75 FINLAND 5.499 82 14.91 14 2.55 37 6.73 10 1.82 FRANCE 64.574 720 11.15 138 2.14 160 2.48 94 1.46 GERMANY 81.762 1,042 12.74 159 1.94 572 7.00 103 1.26 IRELAND 4.668 65 13.92 18 3.86 39 8.35 11 2.36 ISRAEL 8.377 334 39.87 154 18.38 545 65.06 36 4.30 ITALY 60.617 518 8.55 59 0.97 104 1.72 87 1.44 NETHERLANDS 17.008 409 24.05 86 5.06 117 6.88 40 2.35 NORWAY 5.240 120 22.90 27 5.15 32 6.11 8 1.53 SWEDEN 9.824 408 41.53 115 11.71 301 30.64 41 4.17 SWITZERLAND 8.362 346 41.38 104 12.44 230 27.51 47 5.62 UNITED KINGDOM 65.593 979 14.93 246 3.75 275 4.19 110 1.68 CATALONIA 7.516 221 29.40 45 5.99 94 12.51 46 6.12
  17. 17. +100NEW ESTABLISHED COMPANIES FROM2013TO2015 94SPIN-OFFEMERGEDFROM UNIVERSITIES, RESEARCHINSTITUTES ANDHOSPITALS (ACTIVEAT2015) @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia Source: Biotechegate. Biocat Directory, March 2016. The rest of the slides are based on company figures published at Biocat Report 2015 (September 2015) ACLUSTERINEXPANSION BETWEEN2013-2015,ONAVERAGE,3NEWCOMPANIESWEREFOUNDEDPER MONTH(THATIS1NEWVENTUREBORNINHEALTHCAREEVERY10DAYS) 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 8 25 6 23 8 28 3 24 2 25 3 38 3 35 1 41 40 37 31 3 New companies Inactive
  18. 18. Source: BiotechGate. Biocat Directory: Last updated March 2016. Capital raised by companies legally established at the BioRegion (thus it does not include Palobiopharma nor Sanifit) MAB: Spanish sub-market for smaller, growing companies Direct investment MAB Projected December 2015 and March 2016 2009 201120102008 13.56 10.60 10.50 10.61 11.00 29.50 10.68 18 2.44 55.16 3.62 3.44.31 4.3 2012 2013 2014 2015 2016 60 50 40 30 20 10 0 @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia COMPANIESATTRACTEDMORETHAN100M€ ININVESTMENTS(2013-2015) (inM€)
  19. 19. 87%OFBIOREGIONCOMPANIESARESMEs Source: Biocat Directory / SABI Overthepasttwoyears (2013-2015)thenumberof medium-sizedcompanieshas doubledandaccountsfor22% ofallcompanies,whichisa signofprogressive consolidationinthesector @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia Large companiesMedium-sized companies Small companiesMicro-companies 40% 26% 22% 12% BIGCOMPANIESAREMAINLYMULTINATIONALPHARMAS Medium-sized <250 ≤€50M ≤€43M Small <50 ≤€10M ≤€10M Micro <10 ≤€2M ≤€2M Company category Employees Balance sheet total Turnover 734companies
  20. 20. 58%OFCOMPANIESARETRADINGTHEIRPRODUCTSIN INTERNATIONALMARKETS Source: Biocat Internationalization Survey 2015 THEMAINMARKET FORCATALAN COMPANIESISSPAIN Europeisthemain destinationforexportsand internationalsales(mainly Germany,ItalyandFrance) alongwiththeUnitedStates @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia United States Germany United Kingdom Spain Italy France Mexico Brazil China Japan Colombia Canada India Netherlands Australia South Korea Israel Argentina Belgium Sweden 19% 19% 26% 21% 16% 13% 13% 11% 14% 23% 11% 1% 18% 10% 7% 16% 7% 12% 14% 2% 2% 7% 1% 9% 7% 2% 6% 5% 3% 4% 4% 1% 6% 2% 6% 3% 2% 4% 3% 3% 3% 2% 3% 1% 4% 2% 2% 3% 2% 1% 4% 2% 2% 2% 1% 2% 2% 1% 2% 1% Collaborations Future entrySales
  21. 21. @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia BIOTECH:ACTIVITYOFCOMPANIES THERAPIES & DIAGNOSTICS R&D SERVICES BIOTECH-OTHER* ACTIVITIES COMPANIES 45 84 92 *Each company may be included into more than one category Source: Biocat Directory (December 2014) 2013 2015 0 10%5% 20%15% 30%25% 40%35% 45% Environmental AgBio Industrial Biotechnology Nutraceuticals Cosmetics Food Veterinary Others
  22. 22. @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia Source: Biocat Directory Each company can be included in more than one category BIOTECH&PHARMA:ACTIVITYOFCOMPANIES (WORKINGINTHERAPEUTICAREAS) Generics 20% 18% 15% 10% 10% 9% 9% 8% 5,5% 3% 2% 2% 1% 1% 59% Small molecules Anti-infectives Molecular diagnostics Vaccines Drug delivery Antibodies Peptides Proteins Gene therapy Biosimilars Cell therapy Nucleic acid drugs Stem cells Others 0 20% 40% 60%
  23. 23. @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia Source: Biocat Directory BIOTECH&PHARMA:ACTIVITYOFCOMPANIES (OFFERINGSERVICESR&D) CRO Analytical services Diagnostic services CMO Diagnostic instrumentation Synthesis services Genomics Screening Bioinformatics Proteomics Drug delivery Cell culture Biochips Fill & finish 0 10% 20% 30% 40% 36% 25.5% 15% 14% 13% 12% 11% 7.5% 4% 3% 3% 3% 3% 0.5% Others 29.5% Each company can be included in more than one category
  24. 24. @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia BIOTECH&PHARMA:MAINTHERAPEUTICAREAS Neoplasms / cancer / oncology Skin and subcutaneous tissue Infectious and parasitic diseases Diseases of the nervous system Respiratory Musculoskeletal system and connective tissue Genitourinary system Cardiovascular Endocrine, nutritional and metabolic diseases Diseases of the blood and blood-forming organs; immune disorders Digestive system Mental and behavioural disorders Diseases of the eye Pregnancy, childbirth and the puerperium Diseases of the ear Injury, poisoning and certain other consequences of external causes External causes of morbidity and mortality Congenital malformations, deformations and chromosomal abnormalities Conditions originating in the perinatal period 0 10% 20% 30% 40% Source: Biocat Directory 37% 31% 27.5% 27.5% 22% 20% 20% 20% 19% 16.5% 15% 12% 10% 5% 4% 3% 1.5% 1.5% 1.5% 1.5% Each company can be included in more than one category
  25. 25. @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia Source: Biocat Directory MEDTECH:ACTIVITYOFCOMPANIES (WORKINGINR&D,PRODUCTIONANDMARKETINGOFSYSTEMSANDDEVICES FORMEDICALAPPLICATIONSINHUMANSANDANIMALS) Reusable instruments Dental devices Electro mechanical medical devices Single use devices Non-active implantable devices Anesthetic and respiratory devices Imaging Diagnostic devices Ophthalmic and optical devices Technical aids for disabled persons Diagnostic and therapeutic radiation devices Biomaterials Wound Care Delivery devices Hospital Hardware Coatings Regenerative Medicine Others 0 10% 20% 30% 40% COMPANIESWORKINGINMEDTECH: R&D, PRODUCTION & MKT OF MEDICAL DEVICES SOFTWARE, ELECTRONICS, INSTRUMENTATION OR DISTRIBUTION 94 106 200COMPANIES 19.5% 18% 17.5% 15% 12.5% 9.5% 9% 9% 9% 5% 4.5% 4.5% 2% 2% 2% 1% 1% 37% Each company can be included in more than one category
  26. 26. @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia WORLDWIDEINDUSTRYLEADERSCHOOSETHEBIOREGION ASTHEBESTPLACETOINVESTANDDOBUSINESS BIGMULTINATIONALSANDLOCALBIGPLAYERSESTABLISHEDINTHEBIOREGION BIOTECH&PHARMA MEDTECH
  27. 27. @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia ACCELERATINGPROGRAMSINHEALTHCAREATTHEBIOREGION EMPOWERINGSTART-UPSANDENTREPRENEURSTOSCALEUPTHEIRBUSINESSES PROGRAM/ACCELERATOR CAIXAIMPULSE d·HEALTH BARCELONA HEALTH-U SPIRE BIOVENTURES WHAT IF! BARCELONA GRANTS 4 APP TECH4HEALTH BSTARTUP INCUBIO INSPIRIT LABS KAUTIC40 EMPENTA IQSTECHFACTORY STARTUPBOOTCAMP STARTUP NEXT1 WAYRA LIFE SCIENCES LIFE SCIENCES LIFE SCIENCES LIFE SCIENCES LIFE SCIENCES DIGITAL HEALTH DIGITAL HEALTH IT IT IT IT ANY SECTOR ANY SECTOR ANY SECTOR ANY SECTOR ANY SECTOR 6 MONTHS 9 MONTHS 6 MONTHS N/A 8 MONTHS 6 MONTHS 10 MONTHS 6 MONTHS 12 MONTHS N/A 9 MONTHS 5 MONTHS N/A 3 MONTHS 6 WEEKS 12 MONTHS 15 PROJECTS 3-4 PROJECTS 6 START-UPS N/A 10 PROJECTS 4 START-UPS 15 START-UPS 10 START-UPS 7 START-UPS 1-2 PROJECTS 10 PROJECTS 15 PROJECTS N/A 10 START-UPS 10 PROJECTS 10 PROJECTS LA CAIXA BIOCAT SANOFI SPIRE INNOVATION FORUM BAYER HOSPITAL SANT JOAN DE DÉU, ESTEVE, CAIXA CAPITAL RISC, NAE, SHIP2B, DKV BANC DE SABADELL INCUBIO INSPIRIT ORBITAL 40 GENERALITAT DE CATALUNYA, ESADECREÁPOLIS IQS STARTUPBOOTCAMP TECHSTARS TELEFÒNICA INDUSTRY DURATION COHORTSPROMOTERS d·HEALTH BARCELONA 1 Last Startup Next Barcelona edition in April 2016
  28. 28. @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia OURLEADINGTALENT Valenti Fuster, cardiologist Director of Mount Sinai Heart (New York). Editor-in-Chief of the Journal of the American College of Cardiology  (JACC), past President of the  American Heart Association Josep Baselga, oncologist Physician-in-Chief at Memorial Sloan Kettering Cancer Center (New York) Josep M. Gatell, infectious diseases Head of the Infectious Diseases and AIDS Units of the Hospital Clinic of Barcelona  Joan Massagué, oncologist Director of the Sloan-Kettering Institute (New York). Internationally recognized leader in the study of cancer  metastasis and cell behavior Manel Esteller, oncologist Director of the Cancer Epigenetics and Biology Program of the Bellvitge Institute for Biomedical Research (IDIBELL, Barcelona)
  29. 29. @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia SUCCESSSTORIES ASTRAZENECATOBUY RIGHTSTOALMIRALL RESPIRATORYDRUGS
  30. 30. @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia SUCCESSSTORIES GRIFOLSTAKINGARADIGM STAKEINUPTO$116M LICENSINGDEAL
  31. 31. @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia SUCCESSSTORIES CATALANFIRMORYZONTO RECEIVE$21MILIONS FROMROCHETODEVELOP EPIGENETICSDRUGS
  32. 32. @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia SUCCESSSTORIES REIGJOFREANDNATRACEUTICALAGREETO MERGER,CREATINGFIFTHLARGESTPUBLICLY TRADEDPHARMACEUTICALCOMPANY
  33. 33. @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia SUCCESSSTORIES PALOBIOFARMASIGNSLICENSINGAGREEMENTWITHNOVARTISFORIMMUNOTHERAPYTOTREATCANCER
  34. 34. @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia SUCCESSSTORIES THECOMPANY,SPECIALIZEDINDRUGDEVELOPMENTFORRAREORMINORITY DISEASES,GETSMOSTSIGNIFICANTFUNDINGINBIOTECHSECTORINCATALONIA MINORYXTHERAPEUTICSCOMPLETESSERIESAFUNDINGOF€19.4MILLION($21.7M)
  35. 35. @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia SUCCESSSTORIES STAT-DIAGNOSTICA SECURES22.1M$IN SERIESBFINANCING STAT-DIAGNOSTICAANNOUNCES25M€INSERIESCFINANCING
  36. 36. @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia SUCCESSSTORIES SANIFITRAISES€36.6M($41.3M) INSERIESCFINANCINGROUND LEADBYYSIOSCAPITAL
  37. 37. @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia SUCCESSSTORIES AELIXTHERAPEUTICS FINISHESSERIESA THERAPEUTICHIV VACCINEFUNDS
  38. 38. @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia SUCCESSSTORIES MEDTEPCLOSESA$2 MILLIONINVESTMENT ANDMOVESTOSAN FRANCISCO
  39. 39. @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia SUCCESSSTORIES GALGOMEDICAL RAISES€1M INFUNDING
  40. 40. @biocat_en @biocat_es @biocat_cat #BioRegionCatalonia SUCCESSSTORIES BARCELONALEADSTHETOP POSITIONSININNOVATION WORLDWIDERANKINGS
  41. 41. Follow us:

×